Angiodynamics, Inc.
ANGO US03475V1017
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
79% | -53% | -41% | 14% | 1% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Nighan Warren Jr VP |
12.31 USD |
4,060 Sold |
49,979 USD |
16/01/2025 | 16/01/2025 |
Nighan Warren Jr VP |
6.08 USD |
100 Bought |
608 USD |
07/10/2024 | 10/10/2024 |
Trowbridge Stephen A EX VP |
5.86 USD |
1,700 Bought |
9,962 USD |
08/10/2024 | 08/10/2024 |
Clemmer James C CEO |
6.03 USD |
20,000 Bought |
120,600 USD |
07/10/2024 | 07/10/2024 |
Nighan Warren Jr VP |
6.09 USD |
768 Bought |
4,677 USD |
07/10/2024 | 07/10/2024 |
Clemmer James C CEO |
6.70 USD |
10,000 Bought |
67,000 USD |
08/04/2024 | 08/04/2024 |